Product Pipeline
Therapeutics
Pre-clin
Phase 1
Phase 2
Phase 3
NDA/BLA
Phase
Fezagepras (PBI-4050)
Additional Multiple Ascending Dose (MAD) Study
Fezagepras (PBI-4050)
Liver
Fezagepras (PBI-4050)
Kidney